Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rubenstein

Showing results (281-290 of 477) with videos related to

Pageof 48
Sort By:
The Journal of Clinical Investigation|February 1, 1977
Secretion by glucagonomas of a possible glucagon precursorG C Weir, E S Horton, T T Aoki, et al.
Nature|June 25, 1981
A human proinsulin variant at arginine 65D C Robbins, P M Blix, A H Rubenstein, et al.
Diabetes|September 1, 1981
Hepatic extraction of plasma immunoreactive glucagon components. Predilection for 3500-dalton glucagon metabolism by the liverJ B Jaspan, K S Polonsky, S Röjdmark, et al.
Biochemistry|July 21, 1981
Relationship between negative cooperativity and insulin actionJ M Olefsky, A Green, T P Ciaraldi, et al.
The American Journal of Physiology|April 1, 1980
Uridine triphosphate and RNA synthesis during diabetes-induced renal growthP Cortes, N W Levin, F Dumler, et al.
Plos One|March 30, 2018
CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospitalShail M Govani, Peter D R Higgins, Joel H Rubenstein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypesS E Shoelson, S Marshall, H Horikoshi, et al.
Metabolism: Clinical and Experimental|August 1, 1990
Lack of effect of high-dose biosynthetic human C-peptide on pancreatic hormone release in normal subjectsC Wojcikowski, J Blackman, D Ostrega, et al.
JAMA Dermatology|February 22, 2018
Association of Patient Satisfaction With Medical Scribe Use in an Academic Dermatology PracticeVinod E Nambudiri, Alice J Watson, Mitchell H Rubenstein, et al.
The American Journal of Cardiology|March 29, 2001
Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failureM H Rubenstein, B V Sheynberg, L C Harrell, et al.
Pageof 48

Showing results (281-290 of 477) with videos related to

Sort By:
Pageof 48
The Journal of Clinical Investigation|February 1, 1977
Secretion by glucagonomas of a possible glucagon precursorG C Weir, E S Horton, T T Aoki, et al.
Nature|June 25, 1981
A human proinsulin variant at arginine 65D C Robbins, P M Blix, A H Rubenstein, et al.
Diabetes|September 1, 1981
Hepatic extraction of plasma immunoreactive glucagon components. Predilection for 3500-dalton glucagon metabolism by the liverJ B Jaspan, K S Polonsky, S Röjdmark, et al.
Biochemistry|July 21, 1981
Relationship between negative cooperativity and insulin actionJ M Olefsky, A Green, T P Ciaraldi, et al.
The American Journal of Physiology|April 1, 1980
Uridine triphosphate and RNA synthesis during diabetes-induced renal growthP Cortes, N W Levin, F Dumler, et al.
Plos One|March 30, 2018
CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospitalShail M Govani, Peter D R Higgins, Joel H Rubenstein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypesS E Shoelson, S Marshall, H Horikoshi, et al.
Metabolism: Clinical and Experimental|August 1, 1990
Lack of effect of high-dose biosynthetic human C-peptide on pancreatic hormone release in normal subjectsC Wojcikowski, J Blackman, D Ostrega, et al.
JAMA Dermatology|February 22, 2018
Association of Patient Satisfaction With Medical Scribe Use in an Academic Dermatology PracticeVinod E Nambudiri, Alice J Watson, Mitchell H Rubenstein, et al.
The American Journal of Cardiology|March 29, 2001
Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failureM H Rubenstein, B V Sheynberg, L C Harrell, et al.
Pageof 48